| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |